Short News

Print

 

short news

Aspirin Foundation meeting
at FJMC on Oct.5th, 2013

LAHORE: Pakistan Aspirin Foundation is holding its conference at Fatima Jinnah Medical College for Girls Lahore on Saturday October 5th 2013. Prof. Sardar Fakhar Imam Principal FJMC is chairman of organizing committee while Prof. Javed Akram is Convener of the conference. A wide range of topics related to medical uses of Aspirin will be discussed by various speakers followed by a panel discussion. Detailed report to follow.


SAARC ENT conference
at Karachi

KARACHI: First SAARC ENT conference at Karachi from December 19-21st 2013. For details contact Prof. Tariq Rafi, Chairman Organizing Committee Tel: 021-9922310-2 Fax: 021-99223102.


PMA delegation discuss important
issues with Health Secretary

LAHORE: A delegation of PMA met the Secretary Health at Civil Secretariat Lahore last week. The delegation was lead by Dr. Muhammad Tanveer Anwar and included Dr. Izhar Ahmad Ch., Dr. Abrar Ashrar Ali, Dr. Asma Yasin, Dr. Kamran Saeed, Dr. Ehsan-ur-Rehman General Secretary MTA Punjab and Dr. Riaz Zulqarnain Vice President Specialist Doctors Association. The Health Department was represented by Secretary Health, Addl. Secretary Admin, Addl. Secretary Tech, Addl. Secretary Estt and Dy. Secretary Admin.
It was decided that after the approval of the competent authority the summer vacation of medical teachers will be restored, all the Adhoc and contract appointee doctors shall be replaced by regular Doctors. During the month of July the promotion cases of all the doctors working in Grade 19 shall be sent to PSB-I and Secretary Health himself will check the progress on this issue. It was further decided that to attract more qualified and experienced faculty one grade higher appointments criteria to all the four new medical colleges shall be applied.


SKMT Cancer Symposium at
Lahore Nov.31st to Dec. 1st 2013

LAHORE: Shaukat Khanum Cancer Symposium will be held at Lahore from November 31st to December 1, 2013. Fighting cancer on all fronts is the theme of the symposium. Deadline for abstracts is October 15th, 2013. For information and registration contact This email address is being protected from spambots. You need JavaScript enabled to view it.


Many patients may undergo
unnecessary cholesterol testing

According to research published online in JAMA Internal Medicine, about one-third of individuals who have heart disease undergo cholesterol testing more frequently than is recommended by guidelines.
According to another report “more than 9,000 patients out of about 27,000 had additional lipid panels in the 11 months after they achieved an LDL target of <100 mg/dL, and many of the patients had more than one test.” The researchers found that “among patients who met the optional LDL target of <70 mg/dL, almost two-thirds had repeat lipid tests.”


Early follow-up of HF patients
reduce hospital readmissions

Preliminary results from the year-long Southeast Michigan “See You in 7” Hospital Collaborative show that improving early follow-up after discharge can reduce readmissions for patients with heart failure. The purpose of the year-long Collaborative was to improve early follow-up processes for heart failure patients with the goal of reducing readmissions for these patients. The Collaborative focused on process measures from the ACC’s Hospital to Home (H2H) “See You in 7” Toolkit to increase the number of follow-up appointments within seven days of discharge and to improve the quality of these appointments. “The project demonstrated the importance of early follow-up in reducing hospital readmissions, and that when hospitals work together, improvements can be made to our health care system,” said Jill Klaver, Medical Staff Quality Specialist at Crittenton Hospital Medical Center.


Short course of dual antiplatelet therapy
may be beneficial after stroke, TIA

“Final results of the Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events (CHANCE) study, suggesting that a short course of dual antiplatelet therapy appears to be beneficial after stroke or transient ischemic attack (TIA), has now been published in the New England Journal of Medicine.” The research, “which was first presented at the International Stroke Conference (ISC) earlier this year found that the combination of aspirin and clopidogrel given for 21 days with clopidogrel alone continued up to day 90 was more effective than aspirin alone in preventing recurrent strokes in Chinese patients who had had a minor stroke or TIA.” Gene Signature May Predict Aspirin Response, MI Risk. Nearly 60 million Americans take aspirin every day to help prevent heart attacks and stroke,” a study published online Journal of the American College of Cardiology “shows aspirin may not be fully effective for 10 to 15 percent of the population.”


BNP screening, tailored therapy
strategy may help prevent HF

According to research published in JAMA, “screening at-risk patients based on B-type natriuretic peptide (BNP) status and implementing a tailored therapy strategy may help prevent heart failure.” Investigators found, “in the randomized, controlled STOP-HF trial,” that “patients who had an intervention if their BNP levels exceeded 50 pg/mL had a significantly lower risk of a hitting the primary endpoint of asymptomatic left ventricular dysfunction, with or without heart failure, compared with controls (odds ratio 0.55, 95% CI o.37 to 0.82, P=0.003).” The research was “previously reported at the American College of Cardiology (ACC) meeting in March, albeit with a primary endpoint that combined asymptomatic left ventricular (LV) dysfunction with hospitalization for cardiovascular events.”
According to the “Perspective” section of a CardioSource (7/3) “Journal Scan Summary,” the study’s “findings...warrant further validation before BNP should be considered for screening in an at-risk population.”


Less than one in three US patients
have BP, cholesterol under control

“Less than one in three patients in the US have their blood-pressure and cholesterol levels under control, according to” research published in Circulation. Investigators came to this conclusion after assessing “concurrent hypertension and hypercholesterolemia control In [National Health and Nutrition Examination Surveys] 1988 to 1994, 1999 to 2004, and 2005 to 2010.”


Black patients with PAD may have
increased risk of death after CABG

According to to research published in the Annals of Thoracic Surgery, “Black patients with peripheral artery disease have an increased risk of death following heart bypass surgery compared to white patients, and therefore require closer follow-up.” Investigators looked at data on “more than 13,000 patients who underwent coronary artery bypass graft (CABG) surgery,” approximately 11 percent of whom “had peripheral artery disease at the time” of the surgery.
While “white PAD patients were a significant 50% more likely to die than those without PAD over a median of 8 years of post-CABG follow-up, the risk was 2.1 times higher for black PAD patients (95% CI 1.8-2.5).”


Home-Based treadmill program
may benefit patients with PAD

“A home-based treadmill exercise program improved walking speed and endurance in people with...peripheral artery disease (PAD),” according to a study published July 3 in the Journal of the American Medical Association. The study of nearly 200 patients with PAD revealed that those “who did the home-based treadmill exercise program increased their walking distance over six minutes by nearly 150 feet, compared with a decline of 36 feet among patients in a ‘control’ group who did not do the exercise program.”
According to the study authors, “Based on these findings, clinical practice guidelines should advise clinicians to recommend home-based walking programs with a weekly group-mediated cognitive behavioral intervention component for patients with PAD who do not have access to supervised exercise.”


Gene signature may predict
Aspirin response , M.I. risk

“A collection of 60 co-expressed genes – called the Aspirin Response Signature (ARS) – predicted both response to aspirin treatment and the risk of death or myocardial infarction among patients undergoing cardiac catheterization.” Researchers found that “the ARS was significantly associated with platelet function in two groups of healthy volunteers taking 325 mg of aspirin per day, and in a group of cardiology patients taking 81 mg of aspirin per day (P<0.05 for all).” The investigators also found that, “among patients undergoing cardiac catheterization, the ARS was associated with a 30% increased likelihood of death or myocardial infarction (MI), even after adjustment for Framingham risk factors, race, platelet count, and presence of angiographic coronary artery disease.”

© Professional Medical Publications. All rights reserved.